Researcher.Life Logo

Drug Metabolism and Pharmacokinetics : Impact Factor & More

eISSN: 1880-0920pISSN: 1347-4367

Key Metrics

CiteScore
4.5
Eigenfactor
0.001 - 0.005
Impact Factor
< 5
SJR
Q2Pharmacology
SNIP
0.79
Recommended pre-submission checks
Powered by Paperpal by Editage

Topics Covered on Drug Metabolism and Pharmacokinetics

Drug Metabolism and Pharmacokinetics Journal Specifications

Overview
Publisher JAPANESE SOC STUDY XENOBIOTICS
Language English
Frequency Bi-monthly
General Details
LanguageEnglish
FrequencyBi-monthly
Publication Start Year1986
Publisher URLVisit website
Website URLVisit website
View less

Planning to publish in Drug Metabolism and Pharmacokinetics ?

Upload your Manuscript to get

  • Degree of match
  • Common matching concepts
  • Additional journal recommendations
Free Report

Recently Published Papers in Drug Metabolism and Pharmacokinetics

Advances in In silico predictive models for DDI prediction: Implications and practical applications in drug discovery.
  • 1 Jun 2026
  • Drug metabolism and pharmacokinetics
Advances in DDI evaluations: Recent trends from pre-clinical studies to regulatory submissions.
  • 1 Jun 2026
  • Drug metabolism and pharmacokinetics
N6-methyladenosine modification of MRP7 mRNA modulates its expression and paclitaxel sensitivity in lung cancer-derived A549cells.
  • 1 Jun 2026
  • Drug metabolism and pharmacokinetics
Glutathione-reversible inactivation of aldehyde oxidase by hydralazine contributes to inter-lot inhibition variability in human hepatocytes.
  • 1 Jun 2026
  • Drug metabolism and pharmacokinetics
Regulatory impact of G-quadruplexes in the human carboxylesterase 2 gene on drug and lipid metabolism.
  • 1 Jun 2026
  • Drug metabolism and pharmacokinetics
Points to consider in the in vitro estimation of kinetic parameters for quantitative prediction of the drug-drug interactions caused by reversible inhibition of enzymes/transporters.
  • 1 Jun 2026
  • Drug metabolism and pharmacokinetics
Advances in In silico predictive models for DDI prediction: Implications and practical applications in drug discovery.
  • 1 Jun 2026
  • Drug metabolism and pharmacokinetics
Advances in DDI evaluations: Recent trends from pre-clinical studies to regulatory submissions.
  • 1 Jun 2026
  • Drug metabolism and pharmacokinetics
N6-methyladenosine modification of MRP7 mRNA modulates its expression and paclitaxel sensitivity in lung cancer-derived A549cells.
  • 1 Jun 2026
  • Drug metabolism and pharmacokinetics
Glutathione-reversible inactivation of aldehyde oxidase by hydralazine contributes to inter-lot inhibition variability in human hepatocytes.
  • 1 Jun 2026
  • Drug metabolism and pharmacokinetics
Regulatory impact of G-quadruplexes in the human carboxylesterase 2 gene on drug and lipid metabolism.
  • 1 Jun 2026
  • Drug metabolism and pharmacokinetics
Points to consider in the in vitro estimation of kinetic parameters for quantitative prediction of the drug-drug interactions caused by reversible inhibition of enzymes/transporters.
  • 1 Jun 2026
  • Drug metabolism and pharmacokinetics

FAQs on Drug Metabolism and Pharmacokinetics